Trichoscopy and Systemic Scleroderma
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: picture.
- Who it may be relevant to
- Registry conditions: Scleroderma, Systemic. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Prognostic Value of Trichoscopy in Patients With Systemic Scleroderma
Overview
* Few data are available on scalp involvement in systemic scleroderma. * Few data are available on the association between scalp abnormalities and features of systemic scleroderma * Trichoscopy is a simple, reproducible, noninvasive examination that is part of the examination of hairy areas in routine dermatologic practice * There is a lack of simple, noninvasive examinations to evaluate patients with systemic scleroderma The objective will be to evaluate the contribution of trichoscopy in the evaluation of patients with systemic scleroderma
Interventions
- Procedure picture
We will perform a non-invasive assessment of the scalp with a dermoscope by taking two standardized pictures on the frontal area and the occipital area in order to a blinded analysis of trichoscopic patterns
Primary outcome measures
- Frequency of elementary lesions observed by trichoscopic assessment of the scalp [Time frame: Baseline]
Secondary outcome measures (3)
- Correlation between visceral damage of systemic scleroderma and trichoscopic features [Time frame: Baseline]
- Correlation between global severity of systemic scleroderma and trichoscopic features [Time frame: Baseline]
- Correlation between autoimmune profile of sclerodermic patients and trichoscopic features [Time frame: Baseline]
Eligibility criteria
Inclusion criteria
- Patient who fulfils the Systemic scleroderma ACR-EULAR 2013 criteria
- Signed informed consent
- Being social insured
Exclusion criteria
- Patients aged less than 18 years old
- patients under legal protection
- patients deprived of their liberty
- patients in emergency situations
- patients who refused or unable to give informed consent
- For the control group: sclap inflammatory disease active the day of the examination
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Case-control
Study locations
France · 1 center
- Hop Claude Huriez Chu Lille — Lille
Identifiers
NCT: NCT04804930 · 2018_87 · 2020-A00566-33